Chelsea C. Pinnix, MD, PhD
Affiliations: | 2006 | University of Pennsylvania, Philadelphia, PA, United States | |
| 2008- | Radiation Oncology | The University of Texas MD Anderson Cancer Center |
Area:
Radiation Oncology; Lymphoma; Cell BiologyWebsite:
https://faculty.mdanderson.org/profiles/chelsea_pinnix.htmlGoogle:
"Chelsea Pinnix"Cross-listing: MPROTree
Parents
Sign in to add mentor| Meenhard Herlyn | grad student | 2006 | Penn | |
| (Notch1 activation confers transforming properties to primary human melanocytes and promotes human melanoma progression.) | ||||
| Bouthaina S. Dabaja | post-doc | 2012- | The University of Texas MD Anderson Cancer Center (MPROTree) | |
| Charles R. Thomas,Jr | research scientist | The University of Texas MD Anderson Cancer Center (MPROTree) | ||
Collaborators
Sign in to add collaborator| Jillian R. Gunther | collaborator | The University of Texas MD Anderson Cancer Center (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wahid KA, Rooney MK, Gunther JR, et al. (2024) Empirically Derived Principles for Research Funding Success: A Primer for Early Career Academic Investigators. International Journal of Radiation Oncology, Biology, Physics. 118: 590-594 |
| Fang P, Pinnix CC, Wu SY, et al. (2023) Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics |
| Alkhaldi H, Reinhardt A, Barnett M, et al. (2023) HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANT FOR RELAPSED OR REFRACTORY PRIMARY MEDIASTINAL B-CELL LYMPHOMA. Transplantation and Cellular Therapy |
| Steiner RE, Hwang SR, Khurana A, et al. (2023) Impact of Cumulative Dose of Brentuximab Vedotin on Outcomes of Frontline Therapy for Advanced Stage Hodgkin Lymphoma. Blood Advances |
| Wu SY, Fang PQ, Wang EB, et al. (2023) Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma. Advances in Radiation Oncology. 8: 101279 |
| Damron EP, Qazilbash MH, Fang PQ, et al. (2022) Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. Transplantation and Cellular Therapy. 29: 37.e1-37.e7 |
| Afrough A, Alsfeld LC, Milton DR, et al. (2022) Long-term outcomes of allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma. Transplantation and Cellular Therapy |
| Gunther JR, De La Cruz D, Boyce-Fappiano D, et al. (2022) Implementation and Assessment of an Informal Virtual Elective for Medical Student Radiation Oncology Exploration During the COVID19 Pandemic: a Brief Report. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education |
| Steiner RE, Banchs J, Koutroumpakis E, et al. (2021) Cardiovascular events in patients treated with chimeric antigen receptor t-cell therapy for aggressive B-cell lymphoma. Haematologica |
| Kahn JM, Yang JC, Yahalom J, et al. (2021) Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education |